SLRX logo

Salarius Pharmaceuticals (SLRX) Enterprise Value

Enterprise Value

-$865.46 K
-$100.88 K-13.19%

Wed, 27 Nov 2024 14:30:00 GMT

SLRX Enterprise Value Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

SLRX Enterprise Value Performance

PeriodPeriodEnterprise valueEnterprise valueMarket capMarket capPricePrice
todaytoday-13.2%-4.6%-4.6%
1 m1 month-71.3%-14.7%-14.7%
3 m3 months-7.1%-15.2%-15.2%
6 m6 months+55.5%-9.6%-62.5%
ytdytd+71.6%-18.4%-72.1%
1 y1 year+80.3%-23.1%-73.7%
5 y5 years-106.7%-87.1%-99.8%

SLRX Enterprise Value High & Low

PeriodPeriodHighHighCurrent vs highvs highLowLowCurrent vs lowvs low
1 m1 month-$491 K-76.4%-$1 M+16.6%
3 m3 months-$188 K-360.5%-$1 M+29.4%
6 m6 months-$1276<-9999.0%-$3 M+69.9%
1 y1 year-$1276<-9999.0%-$5 M+82.4%
3 y3 years-$1276<-9999.0%-$15 M+94.3%
5 y5 years$62 M-101.4%-$15 M+94.3%
alltimeall time$377 M-100.2%-$15 M+94.3%

Salarius Pharmaceuticals Enterprise Value History

DateValue
2024
-$865.46 K(-71.6%)
2023
-$3.05 M(-64.8%)
2022
-$8.65 M(+27.7%)
2021
-$6.78 M(-161.5%)
2020
$11.02 M(-20.5%)
DateValue
2019
$13.85 M(-456.1%)
2018
-$3.89 M(-108.9%)
2017
$43.63 M(-35.2%)
2016
$67.34 M(-46.7%)
2015
$126.29 M

FAQ

  • What is Salarius Pharmaceuticals enterprise value?
  • What is the all time high enterprise value for Salarius Pharmaceuticals?
  • What is SLRX enterprise value year-to-date change?
  • What is Salarius Pharmaceuticals enterprise value year-on-year change?

What is Salarius Pharmaceuticals enterprise value?

The current enterprise value of SLRX is -$865.46 K

What is the all time high enterprise value for Salarius Pharmaceuticals?

Salarius Pharmaceuticals all-time high enterprise value is $377.17 M

What is SLRX enterprise value year-to-date change?

Salarius Pharmaceuticals enterprise value has changed by +$2.18 M (+71.63%) since the beginning of the year

What is Salarius Pharmaceuticals enterprise value year-on-year change?

Over the past year, SLRX enterprise value has changed by +$3.54 M (+80.35%)